retatrutide weight loss clinical trials results just posted Phase 3 trial showing up to 30% body over 80 weeks. That is approaching bariatric surgery territory, from a medication., It targets three hormone pathways: Experimental drug Retatrutide shows promising
Pay in 4 interest-free payments of $6.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
Experimental drug Retatrutide shows promising results in trial Retatrutide shows 30% weight loss in clinical trial Darshan Shah posted on the topic LinkedIn New Phase 3 retatrutide data just dropped Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Lilly's triple agonist achieves 16.8% weight loss in phase 3 trial The results of the drug are comparable to what is seen with bariatric surgery, according to Eli Lilly. ABC News Retatrutide Side Effects: What Patients Should Know
Store: www.allread.ai · Domain: www.allread.ai

























